diagnostig.com
About company
Diagnostig Limited was established in 2012 as a Point of Care (PoC) diagnostics company. Diagnostig is a spin-out from Bangor University and was created to deliver unique devices for the diagnosis of Mycobacterial infections (including Tuberculosis) based on a proprietary lipid technology. Diagnostig’s core technology centres on the ability to manufacture specific mycolic acids which are components of the cell walls of mycobacteria. The benefits of this approach include: These unique molecules are potent and selective signalling agents in the immune system They have potential as prophylactic and therapeutic agents and can control asthma in an experimental mouse model They have applications as adjuvants The molecules can be used to identify the serum of people infected with active TB Diagnostig are developing simple devices that can be used without access to a specialist laboratory
